We love helping our client’s thrive. And one of them – Oraya Therapeutics – is indeed thriving. Oraya’s IRay AMD Radiotherapy Device is now available in multiple medical facilities in Germany, Switzerland and the United Kingdom. The device addresses Advanced Macular Degeneration (AMD), a progressive disease that causes loss of central vision leading to blindness. It is the primary cause of vision loss for seniors in the industrialized world.
Bridge designed the device using extensive ergonomic studies and a clear understanding of both physician and patient needs. Oraya Therapy – intended as a one-time, non-invasive procedure – uses a low-voltage, stereotactic approach. It delivers precisely controlled X-rays confined to the diseased area of interest, sparing the surrounding structures of the eye. Read more here about Bridge’s Design approach. Watch a news story from BBC showing the device in action.